Trump backs down from 250% EU pharma tariff in deal
Donald Trump backed down from a planned 250% tariff on EU pharmaceuticals. The new US-EU trade deal caps tariffs on medicines and semiconductors at 15%, while further reductions depend on Europe lifting duties on American industrial goods.